10/06/2025
5:51 PM | Bernstein Bruce (Reporting)
TNF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/06/2025
4:29 PM | TNF Pharmaceuticals (Issuer)
RAUCH GARY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2025
4:30 PM | TNF Pharmaceuticals (Issuer)
White Billy Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2025
4:30 PM | Glass Mitchell (Reporting)
TNF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2025
4:30 PM | Friscia Stephen (Reporting)
TNF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2025
4:30 PM | TNF Pharmaceuticals (Issuer)
Silverman Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2025
4:13 PM | TNF Pharmaceuticals (Filer)
| Form 8-K/A | |
10/03/2025
4:28 PM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2025
4:29 PM | TNF Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/26/2025
4:10 PM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2025
4:00 PM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TNFA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TNF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
09/05/2025
4:30 PM | TNF Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/05/2025
4:30 PM | TNF Pharmaceuticals (Filer)
| Form 8-K/A | |
09/02/2025
8:29 AM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2025
4:15 PM | TNF Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2025
4:01 PM | TNF Pharmaceuticals (Filer)
| Form NT 10-Q | |
05/19/2025
4:26 PM | TNF Pharmaceuticals (Filer)
| Form DEFR14A | |
05/09/2025
4:28 PM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
4:30 PM | TNF Pharmaceuticals (Filer)
| Form PRER14A | |
04/21/2025
4:15 PM | TNF Pharmaceuticals (Filer)
| Form DEF 14A | |
04/21/2025
4:20 PM | TNF Pharmaceuticals (Filer)
| Form ARS | |
03/21/2025
4:00 PM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
4:00 PM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:05 AM | TNF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
1:24 PM | Global X Management CO LLC (Filed by)
TNF Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/01/2024
3:30 PM | TNF Pharmaceuticals (Filer)
| Form DEF 14A | |
11/01/2024
3:31 PM | TNF Pharmaceuticals (Filer)
| Form ARS | |
